Show simple item record

dc.contributor.advisorKim, Jung-Whan
dc.creatorHsieh, Meng-hsiung
dc.date.accessioned2019-06-19T23:15:09Z
dc.date.available2019-06-19T23:15:09Z
dc.date.created2018-05
dc.date.issued2018-05
dc.date.submittedMay 2018
dc.identifier.urihttps://hdl.handle.net/10735.1/6608
dc.description.abstractLung squamous cell carcinoma (LSqCC) is one of the subtypes of non-small cell lung cancer (NSCLC) and mostly relate to smoking history. Disregard the first line unspecific chemotherapy, no therapeutic drug had shown successfully target lung SqCC. Fortunately, our previous studies identified an addictive reliance of glucose in SqCC which implicates potential targeted therapeutic strategies. Here, I perform a brief study of ketogenic diet treatment in mice and reveal a significant capability of lowing blood glucose and insulin level. Moreover, Lung SqCC bearing mice with ketogenic diet reveal markedly inhibition of tumour progression. Also, ketogenic diet suppresses PI3K/AKT pathway which aberrantly upregulate in SqCC and promotes cisplatin anti-cancer effect. All in all, this study provides a novel diet treatment for lung SqCC, in which therapeutic options are clinically limited.
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.subjectKetogenic diet
dc.subjectLungs—Cancer
dc.subjectSquamous cell carcinoma
dc.titleThe Anti-Cancer Effect of Ketogenic Diet on Lung Squamous Cell Carcinoma
dc.typeThesis
dc.date.updated2019-06-19T23:17:20Z
dc.type.materialtext
thesis.degree.grantorThe University of Texas at Dallas
thesis.degree.departmentBiology - Molecular and Cell Biology
thesis.degree.levelMasters
thesis.degree.nameMS
dcterms.rights©2018 Meng-hsiung Hsieh. All Rights Reserved.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record